Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beth Israel Deaconess Medical Center (BIDMC) is a world-renowned academic medical center and a major teaching hospital of Harvard Medical School, based in Boston, Massachusetts. It is a leading hub for biomedical research, consistently ranking among the top independent hospitals in the United States for National Institutes of Health (NIH) funding, with an annual research budget exceeding $250 million. BIDMC is particularly noted for its contributions to vaccine development, including the foundational research for the Janssen/J&J COVID-19 vaccine, as well as its leadership in oncology, cardiology, and neurology. As a founding member of Beth Israel Lahey Health, the center operates over 1,000 active research projects and hundreds of clinical trials, making it a critical partner for biotechnology and pharmaceutical companies in the development of novel therapeutics and diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deaconess Medical Center.